Skip to main content
. Author manuscript; available in PMC: 2024 Jan 23.
Published in final edited form as: JACC Cardiovasc Interv. 2023 Jan 23;16(2):209–218. doi: 10.1016/j.jcin.2022.10.062

Table 3:

Comparison of 3-year cumulative incidence of all-cause and cause-specific mortality from the ISCHEMIA-CKD (eGFR <30 mL/min/1.73 m2) and ISCHEMIA (eGFR ≥30 mL/min/1.73 m2) trials

Cumulative Incidence Function ISCHEMIA-CKD (at 3 Year)
(eGFR <30 mL/min/1.73 m2 or on dialysis)
ISCHEMIA (at 3 Year)
(eGFR ≥ 30 mL/min/1.73 m2)
 Randomized Strategy Invasive (N = 388) Conservative (N = 389) Invasive (N= 2,588) Conservative (N = 2,591)
 All-cause death, n (%) 94 (27.2) 98 (27.8) 145 (4.3) 144 (4.3)
Cause-specific death, n (%)
Cardiovascular cause of death 49 (14.6) 45 (12.6) 64 (2.1) 69 (2.2)
  Sudden cardiac death 22 (6.5) 22 (6.0) 28 (0.8) 38 (1.3)
  Heart failure/shock 6 (1.7) 6 (1.5) 9 (0.3) 4 (0.1)
  Acute myocardial infarction 5 (1.6) 10 (3.2) 9 (0.4) 16 (0.4)
  Cardiovascular procedure 6 (1.6) 2 (0.6) 6 (0.2) 6 (0.2)
  Other cardiovascular 10 (3.3) 5 (1.5) 12 (0.4) 5 (0.2)
Non-cardiovascular cause of death 31 (8.4) 28 (8.2) 69 (1.8) 49 (1.3)
  Malignancy 10 (2.8) 4 (1.3) 41 (1.0) 20 (0.4)
  Infection (includes sepsis) 16 (4.7) 16 (4.8) 11 (0.2) 15 (0.5)
  Renal 1 (0.3) 6 (1.7) NA NA
  Other*,2 4 (0.5)1 2 (0.5)1 17 (0.6)2 14 (0.4)2
Undetermined cause of death 14 (4.2) 25 (6.9) 12 (0.4) 26 (0.7)

eGFR = estimate glomerular filtration rate

*

Other in ISCHEMIA-CKD includes hemorrhage not intracranial, non-cardiovascular surgery, pulmonary.

Other in ISCHEMIA includes renal plus GI, pulmonary, suicide, trauma, drug overdose, hemorrhage, hepatic, stroke, ischemic bowel, pulmonary embolism and SAH.